Research and Clinical Trials for Arrhythmia
Research and clinical trials pave the way for new treatment options. Through trials at the Henry Ford Heart & Vascular Institute, we evaluate the safety and effectiveness of new arrhythmia devices, medications and therapies.
How arrhythmia research can help
Today, people with arrhythmia have many choices for treatment, including wireless cardiac devices and procedures that prevent strokes from atrial fibrillation.
These advances are possible because of research and clinical trials here at Henry Ford and around the country. As an academic medical center, we focus on finding new therapies and expanding our diagnostic capabilities.
How clinical trials work
We use trials to test new therapies for arrhythmia care. We carefully research the potential risks and benefits of trial before it ever reaches the people we help.
The types of trials we offer may focus on:
- Finding new ways to program pacemakers and defibrillators for optimal treatment
- Using defibrillators to predict someone’s risk of heart failure and reduce hospitalizations
- Researching alternatives to conventional cardiac resynchronization therapy
Are you eligible for a clinical trial?
Many of our clinical trials test new cardiac devices or new ways to use those devices. People who need a device may be eligible for a trial. Each trial has specific requirements and guidelines for who can participate.
Learn more by searching our clinical trials database for cardiac electrophysiology trials.